Notch signaling pathway is a potential therapeutic target for extracranial vascular malformations
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Notch signaling pathway is a potential therapeutic target for extracranial vascular malformations
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-12-14
DOI
10.1038/s41598-018-36628-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of an angiogenesis animal model featuring brain arteriovenous malformation histological characteristics
- (2016) Chrysanthi Papagiannaki et al. Journal of NeuroInterventional Surgery
- Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
- (2016) D. M. Adams et al. PEDIATRICS
- Notch receptor expression in human brain arteriovenous malformations
- (2015) Sandra Hill-Felberg et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- DLL4 promotes continuous adult intestinal lacteal regeneration and dietary fat transport
- (2015) Jeremiah Bernier-Latmani et al. JOURNAL OF CLINICAL INVESTIGATION
- Epidermal Growth Factor Receptor Inhibition Reduces Angiogenesis via Hypoxia-Inducible Factor-1α and Notch1 in Head Neck Squamous Cell Carcinoma
- (2015) Wei-Ming Wang et al. PLoS One
- Combined deficiency of Notch1 and Notch3 causes pericyte dysfunction, models CADASIL and results in arteriovenous malformations
- (2015) Natalie M. Kofler et al. Scientific Reports
- Targeting Prodromal Alzheimer Disease With Avagacestat
- (2015) Vladimir Coric et al. JAMA Neurology
- Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933
- (2014) Sylvia M. Lee et al. CANCER
- MurineNotch1is required for lymphatic vascular morphogenesis during development
- (2014) Anees Fatima et al. DEVELOPMENTAL DYNAMICS
- A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma
- (2014) Ana De Jesus-Acosta et al. INVESTIGATIONAL NEW DRUGS
- Human brain arteriovenous malformations express lymphatic-associated genes
- (2014) Lorelei D. Shoemaker et al. Annals of Clinical and Translational Neurology
- A review of contemporary options for medical management of hemangiomas, other vascular tumors, and vascular malformations
- (2013) Julie Blatt et al. PHARMACOLOGY & THERAPEUTICS
- Hypoxia-Induced Arterial Differentiation Requires Adrenomedullin and Notch Signaling
- (2013) Fredrik Lanner et al. STEM CELLS AND DEVELOPMENT
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
- (2011) Maryam Fouladi et al. JOURNAL OF CLINICAL ONCOLOGY
- In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract
- (2010) Irina Arnaoutova et al. Nature Protocols
- Notch-1 signalling is activated in brain arteriovenous malformations in humans
- (2009) Q. ZhuGe et al. BRAIN
- Endothelial Notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease
- (2009) Patrick A Murphy et al. LABORATORY INVESTIGATION
- Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis
- (2008) Y. H. Kim et al. DEVELOPMENT
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started